| Rebecca L Smith, MD | |
|
1700 First Baxter Xing, Ste 101, Fort Mill, SC 29708-8919 | |
| (803) 802-3376 | |
| Not Available |
| Full Name | Rebecca L Smith |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 34 Years |
| Location | 1700 First Baxter Xing, Fort Mill, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366412033 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Dermatology Of Sc Pc | 4284864372 | 30 |
News Archive
An unlit, deserted car park at night, footsteps in the gloom. The heart beats faster and the stomach ties itself in knots. We often feel threatening situations in our stomachs.
Anadis Ltd., an Australian biopharmaceutical company specializing in oral immunotherapy using naturally derived antibodies and other proteins is announcing the clinical protocol for its Cancer-related Mucositis Program was cleared by the Tel Aviv Souraski Medical Center's Institutional Review Board (IRB) and by the Israeli Ministry of Health (MOH).
The Washington Post's Fact Checker finds a recent Obamacare poll by the U.S. Chamber of Commerce presented data "in a highly misleading way," while a memo by President Barack Obama's pollster asserts that GOP efforts to repeal the health law have support of only about half of GOP voters.
Reuters reports on how some health experts worry that growing complacency about the threat of measles in Africa is contributing to "some of the largest and most deadly outbreaks in years." Worldwide, "[a]bout 164,000 people died from measles in 2008, down 78 percent from 733,000 in 2000, according to the Measles Initiative," Reuters reports, adding that "UNICEF fears the combined effect of decreased political and financial commitment to measles could reverse the gains, resulting in an estimated 1.7 million measles-related deaths globally between 2010 and 2013."
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
› Verified 3 days ago
| Entity Name | Advanced Dermatology Of Sc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255754008 PECOS PAC ID: 4284864372 Enrollment ID: O20140312000656 |
News Archive
An unlit, deserted car park at night, footsteps in the gloom. The heart beats faster and the stomach ties itself in knots. We often feel threatening situations in our stomachs.
Anadis Ltd., an Australian biopharmaceutical company specializing in oral immunotherapy using naturally derived antibodies and other proteins is announcing the clinical protocol for its Cancer-related Mucositis Program was cleared by the Tel Aviv Souraski Medical Center's Institutional Review Board (IRB) and by the Israeli Ministry of Health (MOH).
The Washington Post's Fact Checker finds a recent Obamacare poll by the U.S. Chamber of Commerce presented data "in a highly misleading way," while a memo by President Barack Obama's pollster asserts that GOP efforts to repeal the health law have support of only about half of GOP voters.
Reuters reports on how some health experts worry that growing complacency about the threat of measles in Africa is contributing to "some of the largest and most deadly outbreaks in years." Worldwide, "[a]bout 164,000 people died from measles in 2008, down 78 percent from 733,000 in 2000, according to the Measles Initiative," Reuters reports, adding that "UNICEF fears the combined effect of decreased political and financial commitment to measles could reverse the gains, resulting in an estimated 1.7 million measles-related deaths globally between 2010 and 2013."
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca L Smith, MD 1700 First Baxter Xing, Ste 101, Fort Mill, SC 29708-8919 Ph: (803) 802-3376 | Rebecca L Smith, MD 1700 First Baxter Xing, Ste 101, Fort Mill, SC 29708-8919 Ph: (803) 802-3376 |
News Archive
An unlit, deserted car park at night, footsteps in the gloom. The heart beats faster and the stomach ties itself in knots. We often feel threatening situations in our stomachs.
Anadis Ltd., an Australian biopharmaceutical company specializing in oral immunotherapy using naturally derived antibodies and other proteins is announcing the clinical protocol for its Cancer-related Mucositis Program was cleared by the Tel Aviv Souraski Medical Center's Institutional Review Board (IRB) and by the Israeli Ministry of Health (MOH).
The Washington Post's Fact Checker finds a recent Obamacare poll by the U.S. Chamber of Commerce presented data "in a highly misleading way," while a memo by President Barack Obama's pollster asserts that GOP efforts to repeal the health law have support of only about half of GOP voters.
Reuters reports on how some health experts worry that growing complacency about the threat of measles in Africa is contributing to "some of the largest and most deadly outbreaks in years." Worldwide, "[a]bout 164,000 people died from measles in 2008, down 78 percent from 733,000 in 2000, according to the Measles Initiative," Reuters reports, adding that "UNICEF fears the combined effect of decreased political and financial commitment to measles could reverse the gains, resulting in an estimated 1.7 million measles-related deaths globally between 2010 and 2013."
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
› Verified 3 days ago
Julie Patricia Iannini, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1700 First Baxter Xing, Ste 101, Fort Mill, SC 29708 Phone: 803-802-3376 | |
Dr. Euphemia W Mu, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 485 Tom Hall St Ste 101, Fort Mill, SC 29715 Phone: 803-228-7972 Fax: 803-228-7974 | |
Megan R Joint, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 485 Tom Hall St Ste 101, Fort Mill, SC 29715 Phone: 803-228-7972 |